We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+8.53%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$363M
AUM Growth
+$13.2M
Cap. Flow
+$3.91M
Cap. Flow %
1.08%
Top 10 Hldgs %
35.6%
Holding
94
New
25
Increased
21
Reduced
19
Closed
23

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$13.4M
2
BIIB icon
Biogen
BIIB
+$10.6M
3
UHS icon
Universal Health Services
UHS
+$9.83M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.37M
5
SNY icon
Sanofi
SNY
+$9.13M

Top Sells

Rank Stock Value
1
NTLA icon
Intellia Therapeutics
NTLA
+$10.9M
2
CRL icon
Charles River Laboratories
CRL
+$10.1M
3
MCK icon
McKesson
MCK
+$9.75M
4
CNC icon
Centene
CNC
+$9.59M
5
NVST icon
Envista
NVST
+$7.16M

Sector Composition

Rank Sector Weight
1 Healthcare 93.34%
2 Energy 2.32%
3 Industrials 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNC icon
76
Centene
CNC
$32.4B
– –
-150,000
Closed -$9.59M
CRL icon
77
Charles River Laboratories
CRL
$13.3B
– –
-35,000
Closed -$10.1M
CVS icon
78
CVS Health
CVS
$120B
– –
-20,000
Closed -$1.5M
EXEL icon
79
Exelixis
EXEL
$12.9B
– –
-200,000
Closed -$4.52M
INSM icon
80
Insmed
INSM
$29.3B
– –
-70,000
Closed -$2.38M
KZR
81
DELISTED
Kezar Life Sciences
KZR
– –
-2,000
Closed -$119K
LH icon
82
Labcorp
LH
$26.1B
– –
-29,100
Closed -$6.38M
MCK icon
83
McKesson
MCK
$104B
– –
-50,000
Closed -$9.75M
MGNX icon
84
MacroGenics
MGNX
$253M
– –
-175,000
Closed -$5.57M
MRK icon
85
Merck
MRK
$322B
– –
-94,320
Closed -$6.94M
PODD icon
86
Insulet
PODD
$9.91B
– –
-10,000
Closed -$2.61M
RARE icon
87
Ultragenyx Pharmaceutical
RARE
$2.65B
– –
-10,000
Closed -$1.14M
THC icon
88
Tenet Healthcare
THC
$21B
– –
-50,000
Closed -$2.6M
TVTX icon
89
Travere Therapeutics
TVTX
$5.81B
– –
-15,000
Closed -$375K
VRTX icon
90
Vertex Pharmaceuticals
VRTX
$134B
– –
-14,000
Closed -$3.01M
SWAV
91
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-10,000
Closed -$1.3M
NSTG
92
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-65,000
Closed -$4.27M
SGFY
93
DELISTED
Signify Health, Inc.
SGFY
– –
-160,000
Closed -$4.68M
HZNP
94
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-40,000
Closed -$3.68M
1 2 3
4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Integral Health Asset Management held 94 positions worth $363M, up 3.8% from $350M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Integral Health Asset Management's Q2 2021 filing shows 25 new, 21 increased, 19 reduced and 23 closed positions. Its largest new stake was Biogen: 35,000 shares worth $12.1M. The largest sale was Intellia Therapeutics, an estimated $10.9M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier, followed by Energy and Industrials.

  • Integral Health Asset Management's largest Q2 2021 buy was Biogen: 35,000 shares worth $12.1M.
  • Integral Health Asset Management added most to Elevance Health in Q2 2021, an estimated $13.4M increase.
  • Integral Health Asset Management's biggest Q2 2021 reduction was Intellia Therapeutics, cutting an estimated $10.9M.
  • Integral Health Asset Management fully exited Charles River Laboratories in Q2 2021, selling an estimated $10.1M.
  • Integral Health Asset Management's ten largest holdings make up 36% of its $363M portfolio in Q2 2021.
  • Integral Health Asset Management opened 25 new positions and closed 23 in Q2 2021.
  • Integral Health Asset Management's portfolio value rose 3.8% quarter-over-quarter to $363M.

Based on Integral Health Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.